NCT00190879已完成4 期
Phase IV Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 440
- 试验地点
- 22
- 主要终点
- Reduction in signs and symptoms of ADHD as measured by the mean changes from baseline to endpoint in Conner's adult ADHD rating scale
研究概览
简要总结
To investigate the effect of atomoxetine hydrochloride in treating adults who have attention deficit hyperactivity disorder with comorbid social anxiety disorder
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •You must be 18 to 65 years old.
- •You must have been diagnosed with attention deficit hyperactivity disorder and social anxiety disorder.
- •You must be able to visit the doctor's office at least 8 times over a 16 week period.
- •You must agree to participate with all tests and examinations that are required for this study.
排除标准
- •You are a woman and pregnant or breastfeeding.
- •You presently have an acute or unstable medical illness.
- •You have a history of allergic reaction to atomoxetine hydrochloride.
- •You are taking medications that are not permitted in this study. Your physician will discuss these with you.
- •You have taken part in another clinical research trial within the last 30 days or have received treatment with a drug in the last 30 days that has not received regulatory approval.
结局指标
主要结局
Reduction in signs and symptoms of ADHD as measured by the mean changes from baseline to endpoint in Conner's adult ADHD rating scale
次要结局
- Reduction in signs and symptoms of social anxiety as measured by the mean changes from baseline to endpoint in Liebowitz social anxiety scale
研究者
研究点 (22)
Loading locations...
相似试验
已完成
4 期
Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid DyslexiaDyslexiaAttention Deficit Hyperactivity DisorderNCT00607919Eli Lilly and Company209
已完成
4 期
Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional OutcomesAttention Deficit Hyperactivity DisorderNCT00510276Eli Lilly and Company445
已完成
1 期
Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHDAttention Deficit Disorder With Hyperactivity (ADHD)Attention Deficit Disorder (ADD)Fetal Alcohol SyndromeNCT00417794University of Oklahoma38
已完成
2 期
Atomoxetine and Huntington's DiseaseChoreaHuntington DiseaseNCT00368849University of Iowa20
撤回
4 期
Efficacy of Atomoxetine for ADHD in Adolescents and Young Adults With SUDSubstance Use DisorderAttention Deficit Hyperactivity DisorderNCT01207622Massachusetts General Hospital